We have examined the effects of the murine ligand (FL) for the fk3/f/&Z tyrosine kinase receptor on the proliferation of murine lymphohematopoietic progenitors as well as committed myeloid and B-cell progenitors. In the presence of erythropoietin, FL alone supported scant colony formation from enriched marrow cells of normal mice. However, when it was combined with interleukin-3 (IL-3). steel factor (SF), or IL-11, FL significantly enhanced colony formation. When tested on enriched marrow cells from 5-fluorouracil (5-FU)-treated mice, FL neither enhanced IL-3-dependent colony formation nor synergized with SF in support of colony formation. However, FL synergized with IL-6, IL-11, or HE RECEPTOR-TYPE tyrosine kinases comprise a large family of proteins that are important in the proliferation and differentiation of a number of cells. Among them, c-fms,' kit,'-^ Jlt3,' and Jk2' are grouped into a subfamily based on organization and sequence similarities. c-fms, a receptor for colony-stimulating factor 1 (CSF-I) or macrophage CSF, is involved in the proliferation and differentiation of macrophage precursors and is required for the survival, proliferation, and differentiation of mononuclear phagocytes, including osteoclast^.^-^ c-kit appears essential for the development of melanoblasts, germ cells, and hematopoietic cells. The W and SI loci encode c-kit and its ligand, steel factor (SF), respectively>'""3 and mutations in these genes cause white spotting, infertility, and severe defects in the hematopoietic c-kit and SF also play important roles in survival, proliferation, and differentiation of primitive lymphohematopoietic progenitor^'^.'^ as well as in early B and T lymphopoiesis.20~22 Matthews et a16,2' attempted to identify hempoietic stem cell-specific genes that encode tyrosine kinase-type receptors and have cloned two cDNAs, designated fetal liver kinase 1 Vkl) andJlk2 from fetal liver cells that were enriched for hematopoietic stem and progenitor populations. Jlk2 is nearly identical to Jlt3, which was independently cloned from murine placenta5 and also from a population of cells that are phenotypically early T-cell progenitors (CD3-, CD4-, and CDK) derived from a day 13 murine fetal li~er.'~Jlt3 andJlk2 are nearly identical 
in amino acid sequences except for two amino acids in the extracytoplasmic domain and 31 amino acids near their Ctermini in the cytoplasmic domain.24 It is likely that they are encoded by one gene and share the same ligand.24 The human homolog of murineJlt3gk2 was cloned from both a pre-Bcell line" and bone marrow cells that were enriched for hematopoietic stem cells (stem cell tyrosine kinase 1, STKl"). Because of their expression by primitive hematopoietic progenitors"" and lymphoid precursors'.'' and their structural similarity to c-fms and c-kit, it has been speculated that Jlt3/Jlk2 may be important in early lymphohematopoiesis. This hypothesis was in part supported by a study showing that antisense oligonucleotides directed against the STK-1 sequence inhibited hematopoiesis in vitro.* ' Recently cDNAs of murine and human ligands (FL) for jZt34t2 have been ~l o n e d .~~.~~ Here we report that murine FL can support proliferation of primitive murine lymphohematopoietic progenitors in synergy with interleukin-6 (IL-6). IL-1 1 , or granulocyte colony-stimulating factor (G-CSF) and that FL can also support proliferation of B-cell progenitors alone and in combination with SF or IL-7.
MATERIALS AND METHODS
Growth factors. Recombinant, soluble murine FL was expressed in yeast and purified as previously described.*' Purified recombinant human IL-la was provided by Dr Hirai (Otsuka Pharmaceutical CO, Ltd, Tokushima, Japan). Purified recombinant murine IL-3 was purchased from R & D Systems (Minneapolis, MN). The medium conditioned by Chinese hamster ovary (CHO) cells that have been genetically engineered to produce murine IL-3 was a gift from T. Sudo of Biomaterial Research Institute (Yokohama, Japan). Purified recombinant murine IL-4 and human IL-7 were provided by C. Faltynek of Sterling Drug (Malvern, PA). Purified recombinant human IL-6 was a gift from M. Naruto of Toray Industries (Yokohama, Japan). Purified recombinant human IL-l1 and murine IL-12 were gifts of P. Schendel and S.F. Wolf of the Genetics Institute, Canbridge, MA, respectively. Purified recombinant murine SF was provided by Kirin Brewery CO (Tokyo, Japan). Conditioned medium (CM) of C H 0 cells that had been transfected with an expression plasmid containing murine SF cDNA was provided by D. Donaldson of the Genetics Institute. Purified bacterially derived human G-CSF was provided by Dr L. Sousa (Amgen, Thousand Oaks, CA). Purified recombinant human erythropoietin (Epo) was provided by the Genetics Institute Clinical Manufacturing Group. Serum-free CM of pokeweed mitogen-stimulated spleen cells (PWM-SCM) was prepared as described.'" Unless specified otherwise, C H 0 cell CM (CHO- CM) was used as source of IL-3 and SF. The concentrations of cytokines used were as follows: IL-la, 1 ng/mL; L -3 (purified), IO ng/mL; IL-3 (CHO-CM), 200 U/mL; IL-4, 10 ng/mL; L-6, 100 ng/ mL; IL-7, 5 ng/mL; L-11, 100 ng/mL; IL-12, 10 ng/mL; SF (purified), 100 ng/mL; SF (CHO-CM), 5 U/mL; G-CSF, 1.0 ng/mL; Ep, Progenirorpurification. Bone marrow cells were harvested from IO-to 16-week-old normal BDFl mice (Charles River, Raleigh, NC) and from mice injected intravenously with 5-fluorouracil (5-FU; Adria Laboratories, Colombus, OH) at 150 m a g (body weight) 2 days before. The marrow cells from normal and 5-FU-treated mice were enriched for progenitors using the technique we described previo~sly.~' Briefly, cells at densities ranging from 1.063 to 1.0770 g/ mL were procured with metrizamide (Accurate Chemical & Scientific, Westbury, NY) density centrifugation, and cells expressing lineage-specific antigens were removed by negative immunomagnetic bead selection using a cocktail of monoclonal antibodies (MoAbs) and Dynabeads M-450 sheep-antirat IgG (Dynal, Great Neck, NY). The MoAbs used were antGB220 (14. Clonal myeloid cell culture. One hundred Lin-Ly-6AE' marrow cells from normal mice and 50 marrow cells from 5-FU-treated mice were plated in 35-mm suspension culture dishes (Becton Dickinson Labware, Lincoln Park, NJ). The culture medium consisted of a medium (Flow Laboratories, Rockville, MD), 1.2% 1500-centipoise methylcellulose (Shinetsu Chemical, Tokyo, Japan), 25% fetal calf serum (FCS; Intergen, Purchase, NY), 1% deionized fraction V bovine serum albumin (BSA, Sigma Chemical CO, St Louis, MO), 0.1 mmol/L 2-mercaptoethanol (2-ME, Sigma), Epo, and designated growth factors. Dishes were incubated at 37°C in a humidified atmosphere flushed with 5% CO,. Colonies consisting of 50 or more cells were scored on day 13 of incubation. Colonies were identified using the criteria described previo~sly.'~~~'
Analysis of myeloid and B-lymphoid potentials of the progenitors. Study of myeloid and B-lymphoid potentials of progenitors was performed using 3 minor modifications of the two-step methylcellulose culture system described previously." First, 150 Lin-Ly-6A/ E' cells from 5-FU-treated mice were plated in primary methylcellulose culture containing a medium, 1.2% methylcellulose, 25% FCS, 1 % BSA, 0. l mmol/L 2-ME, FL, Epo, IL-7, and either IL-6, IL-I 1, or G-CSF. On day 1 I of culture, 24 or 36 primary colonies were individually picked, washed, and aliquots of cells from each primary colony were replated in secondary methylcellulose culture containing SF and IL-7 for assessment of pre-B-cell colony formation. The number of pre-B-cell colonies was scored on day 11 of secondary culture by using the criteria described." Simultaneously, aliquots of cells from each primary colony were cultured without methylcellulose in 96-well plates in the presence of FL, Epo, and IL-6, IL-11, or G-CSF, depending on which factor was used in the primary culture, and small samples of cells were procured every 2 to 3 days for cytologic examination of myeloid lineage expression.
Second, to test the direct effects of growth factors, Lin-Ly-6A/ E+CD43b"8h' cells from 5-W-treated mice were individually plated by micr~manipulation~~ in primary culture containing FL and either 2 U/mL; PWM-SCM, 5% (voVVOI).
IL-6, IL-11, or G-CSF. Epo and IL-7 were omitted. On day 11 or 12, the primary colonies were individually picked, washed, and aliquots of each primary colony were replated in secondary pre-Bcell colony culture containing SF and IL-7. Aliquots of cells from each primary colony were simultaneously recultured in two different myeloid suspension cultures in 96-well plates. One was performed in the presence of FL, Epo, and IL-6, IL-I I, or G-CSF, depending on which factor was used in the primary culture. The other one was performed in the presence of IL-3, PWM-SCM, and Epo. Myeloid lineage expression was examined cytologically every 2 to 3 days after the reculture.
Third, to test the inhibitory effects of IL-3 and IL-la on the Blymphoid potential of progenitor cells, 150 Lin-Ly-6A/E+ post-5-FU marrow cells were plated in methylcellulose cultured with FL and IL-6, IL-1 I, or G-CSF in the presence or absence of IL-3 and IL-la. On day 10 of culture, after total colony numbers were scored, 30 primary colonies were picked, pooled, and washed. Aliquots of 1/60 of the pooled cells were then replated in secondary pre-B-cell colony culture containing SF and IL-7.
Purijication of B-cell progenitors from normal bone marrow and induction of B220' cells. Bone marrow cells procured from normal BDFl mice were enriched for Mac-I-Gr-l-L3T4-Ly-2-TERI 19-(M-T-E-) cells by negative immunomagnetic bead selection using a cocktail of antibodies and Dynabeads M-450 sheepantirat IgG. M-T-E-cells were then stained with biotin-conjugated anti-B220 (RA3-6B2, PharMingen, San Diego, CA)43 and PE-conjugated streptavidin (Jackson ImmunoResearch Lab, Inc, West Grove, PA) and sorted for B220-cells and B220+ cells. Sorted B220-and B220' cells were more than 97% pure. Biotin-rat IgG2a (Caltag) was used as an isotype control antibody. Ten thousand M-T-E-B220-and M-T-E-B220+marrow cells were then cultured with combinations of growth factors in a 24-well plate. The culture medium consisted of a medium, 25% FCS, 1% BSA,and 0.1 mmol/L 2-ME. On day 11 of incubation, all cells were recovered from the wells and analyzed for B220 expression using a flow cytometer. Dead cells were gated out using forward v side-scatter window and staining with propidium iodide (Sigma).
RESULTS

Effects of FL on colony formation from normal marrow
cells. First we examined the effects of FL, as a single factor or in combination with other cytokines, on colony formation from Lin-Ly-6A/E+ cells of normal mice. The results presented in Table 1 are representative of three experiments. As single agents, FL, SF, and IL-11 supported formation of a small number of granulocyte-macrophage (GM) colonies. IL-3 supported formation of more colonies, including multilineage colonies, than other single factors. When FL and IL-3 were combined, the total colony formation was significantly enhanced. Similarly, synergy was obvious between FL and SF and between FL and IL-11 for GM colony formation. Interestingly, many of the colonies supported by FL and IL-11 contained a number of immature cells, therefore it was not possible to determine the colony types in situ.
Direct effects of FL on primitive progenitors of post-5-FU marrow cells. To examine in more detail the effects of F'L on primitive progenitors we next studied colony formation from Lin-Ly-6A/E+ post-5-FU marrow cells. The results are presented in Table 2 . The data are representative of three experiments. In these experiments we also tested possible synergy with other cytokines that have been shown to act on early hematopoiesis, ie, SF, IL-3, IL-4, IL-6, IL- t Difference is significant at P < ,005. t Difference is significant at P < ,001.
9
In situ diagnosis was not done.
11, IL-12, and G-CSF.'6~'y~''"s' None of the individual factors except IL-3 supported colony formation. FL did not synergize with SF, IL-3, or IL-4. The lack of synergy between FL and IL-3 and between FL and SF was in contrast to the synergy between IL-11 and SF, IL-3, or IL-4 in support of colony formation including granulocyte/erythrocyte/macrophage/megakaryocyte (GEMM) colonies and to the studies with normal marrow cells shown in Table 1 . Similar to SF, FL enhanced colony formation when combined with either IL-6, IL-1 1, or G-CSF. However, the number of colonies was significantly smaller than that supported by SF-containing combinations, and FL did not synergize with IL-12. Upon cytologic examination, many colonies supported by FL plus one of IL-11, IL-6, and G-CSF again showed the presence of blast cells and no erythroid or megakaryocytic elements. Therefore, accurate in situ identification of colony types was not possible.
Lineage expression of colonies supported by FL. In culture of both normal and post-5-FU marrow cells, it was not possible to identify colony types in situ on day 13 of culture because of persistence of blast cells. To study if this is due to delayed differentiation and maturation of the colonies, we extended the culture period up to 30 days and performed serial cytologic examination of the cultures. We plated 150 Lin-Ly-6A/E' post-5-FU marrow cells in the presence of FL, Epo, IL-7, and IL-6, IL-11, or G-CSF. On day 1 1 of culture, we randomly picked 24 or 36 colonies and replated aliquots of the colonies individually in 96-well plates without methylcellulose in the presence of FL, Epo, and either IL-6, IL-11, or G-CSF, depending on which factor was used in the primary culture. Every 2 to 3 days after reculture until day 30, small samples of each culture were procured for cytologic assessment of the myeloid potentials of the progenitors. Simultaneuosly, aliquots of each primary colony were recultured in methylcellulose in the presence of SF and IL-7 to test the ability to form pre-B-cell colonies. The cumulative myeloid and B-lymphoid lineage expression of the progenitors that yielded sufficient number of cells for the analysis are shown in Table 3 . The data are representative of three experiments. Various combinations of myeloid lineages were seen. Most colonies showed only mature myeloid cells by day 26 of culture. In two secondary myeloid cultures supported by F L , IL-11, and Epo, blast cells still predominated even on day 30. Approximately one third of the primary colonies yielded pre-B-cell colonies. There were no obvious differences in the myeloid potentials between colonies containing B-lymphoid potential and those showing no lymphoid potential. One hundred fifty post-5-FU Lin-Ly-6NE' cells were cultured with FL, IL-7, Ep, and either IL-11, IL-6, or G-CSF in methylcellulose. On day 11 of incubation, 36 or 24 primary colonies were individually picked from each group and three thirteenths of each primary colony were recultured with SF and IL-7 in methylcellulose for analysis of pre-B-cell colony formation. Pre-B-cell colonies were scored on day 11 of secondary culture. Six thirteenths of each primary colony was cultured with FL, Ep, and either IL-6, IL-11, or G-CSF to match the factors in primary culture in a 96-well plate without methylcellulose. Small samples of cells were harvested every 2 or 3 days until day 30 and stained with May-Grunwald Giemsa for cytologic examination.
Abbreviations: n, neutrophil; m, macrophage; E, erythroblast; M, megakaryocyte; blast, blast cell. were omitted. On day 10 or 12 of culture, primary colonies were individually picked and aliquots of each primary colony were individually tested for B-lymphoid and myeloid potentials in secondary pre-B -cell colony and myeloid suspension cultures. Results are summarized in Table 4 . Of a total of 105 isolated cells cultured with FL and IL-6, 24 cells (23%) yielded primary colonies, of which 4 (17%) gave rise to pre-B-cell colonies in the secondary culture. Similarly, in the Post-5-FU Lin-Ly-6NEt CD43b'ight cells were individually plated using micromanipulation into culture containing designated factors. On day IO, primary colonies were individually picked and a part of cells were replated in methylcellulose with SF and IL-7 for studies of pre-B-cell colony-forming ability.
Myeloid and B-lymphoid potentials
* Primary colonies were harvested and recultured on day 12. One hundred fifty Lin-Ly-GNE' post 5-FU marrow cells were CUItured in the presence of designated factors. On day 10 of the culture, colony number was scored, and 30 colonies were picked and washed. Aliquots of 1/60 of the pooled cells were plated in secondary culture containing SF and IL-7. The number of pre-B-cell colonies was counted on day 11 of secondary culture. Purified IL-3 was used in this experiment.
presence of FL and IL-11, 12 of 98 isolated cells (12%) yielded primary colonies, 17% of which (2 of 12) gave rise to pre-B-cell colonies. And in the presence of FL and G-CSF, 6 of 49 cells (12%) yielded primary colonies, 17% of which (1 of 6) gave rise to pre-B-cell colonies. Part of the study (FL + IL-6, FL + IL-11) was duplicated on two different dates. Myeloid potential was tested under two different conditions of secondary myeloid suspension culture, one containing IL-3, PWM-SCM, and Epo and the other containing FL, Epo, and either IL-6, IL-11, or G-CSF, depending on which factor was used in the primary culture. Small samples of each culture were procured every 2 or 3 days for serial cytologic assessment of the myeloid potentials of the progenitors. Except for four cells that did not yield sufficient number of cells for the analyses, all cells that gave rise to primary colonies showed differentiation along myeloid lineages (data not shown). These results confirmed the direct effects of FL in support of the clonal proliferation of primitive lymphohematopoietic progenitors.
Inhibitory effects of IL-3 and IL-la on the B-lymphoid expression supported by FL. We have reported recently that IL-3 and IL-la can abrogate the B-cell potential of the primary colonies supported by SF.52 Therefore, we tested if IL-3 and IL-la negatively affect the FL-based B-lymphoid expression of the primitive progenitors. The results shown in Table 5 with that of SF. We prepared two sets of B-cell progenitor populations from normal bone marrow. M-T-E-marrow cells were sorted based on B220 expression (Fig 1) . Ten thousand M-T-E-B220-cells and M-T-E-B220' cells were cultured in suspension with growth factors for 11 days, and the number of B220' cells were analyzed by flow cytometry. The results presented in Fig 2 are representative of three experiments. The detection threshold of the B220' cells after 11 days of culture was 3 X 10' cells. IL-7 alone maintained the survival of B220+ cells. However, IL-7 did not support production of B220+ cells from M-T-E-B220-marrow cells. SF alone did not support survival or production of B220' cells from either population. However, in contrast with SF, FL alone supported the production of significant number of B220+ cells from M-T-E-B220-marrow cells. Although the number of the B220' cells was only 5-times more than the detection threshold and about 100-times less than that supported by IL-7 and SF, this effect of FL was shown repeatedly and only with M-T-E-B220-cells. FL acted synergistically with IL-7 giving rise to B220+ cells from both M-T-E-B220-and M-T-E-B220' marrow cells. FL synergized with SF in production of B220' cells from M-T-E-B220-marrow cells, but not from M-T-E-B220+ marrow cells. Addition of FL to the combination of SF and IL-7 enhanced 3-to 5-fold B220' cell production from both populations of cells.
DISCUSSION
The presence of$t3/$k2 tyrosine kinase receptor on murine fetal liver primitive hematopoietic progenitors: human bone marrow primitive hematopoietic progenitors," and murine immature thymocytes,6 suggests that the ligands for the receptor is important in hematopoiesis as well as in lymphopoiesis. Recently, both murine and human FL have been cloned and proven to stimulate the proliferation of hematopoietic progenitor cells and fetal thyrn~cytes.*~-'~ In our study, FL plus IL-6, IL-1 1, or G-CSF supported the proliferation of primitive hematopoietic progenitors including lym-HIRAYAMA ET AL phohematopoietic progenitors that are capable of differentiation along both myeloid and B-lymphoid lineages. Earlier, we observed that both IL-3 and SF act synergistically with IL-6, G-CSF, IL-1 1, or IL-12 in support of colony formation from dormant murine hematopoietic progenitors,'"~''~4'.4h~4". 50 and that SF-, but not IL-3-containing two-factor combinations, support B-cell potential of lymphohematopoietic progenitor~.'~ In this regard, FL was similar to SF, although the number and size of the colonies supported by FL-containing factor combinations were smaller than those supported by SF-containing factor combinations and FL did not synergize with IL-12. FL, like SF, synergized with IL-7 in support of proliferation of B-cell progenitors. These functional redundancies between SF and FL might be explained by their common enzymatic role as a tyrosine kinase, and SF and FL might share common signal transduction pathways.
However, there were differences between FL and SF in their effects on both lymphohematopoietic progenitors and B-cell progenitors. The progeny of Lin-Ly-6AE' progenitors remained blastic much longer than the colonies supported by respective SF-containing cytokine combinations, especially in cultures containing FL plus IL-11. This may indicate only time-course differences or may signify more fundamental differences in the effects of the two cytokines on the differentiation of the progenitors. Studies are under way to clarify the mechanisms of apparent differences in the effects of FL and SF. Second, FL by itself supported the proliferation of B-cell progenitors and their maturation to B220+ cells, whereas SF alone did not. FL synergized with SF in support of the proliferation of B-cell progenitors. In this context, FL behaved like a B-cell factor. However, the targets of FL may be at earlier stages of B-lymphopoiesis than those of IL-7, because FL and FL plus SF supported cell proliferation only from M-T-E-B220-progenitors, but not from B220+ progenitors. In contrast, IL-7 showed effects on M-T"E-B220' progenitors and the synergistic interaction between IL-7 and SF was observed with both B220 t and Although we have documented the effects of FL on primitive lymphohematopoietic progenitors in culture, the significance of our observations in the physiology of early hematopoiesis is unknown. The transgenic jlt3/'k2 null mice showed no apparent defects in myelopoiesis. The overlapping in vitro effects of FL and SF indicate physiologic redundancy in the cytokine regulation of early hematopoiesis. In the fetal liver of SVSZ mice there are significant number of hematopoietic progenitor^,'^ indicating that hematopoiesis in the fetal liver is regulated by mechanisms other than SF. Because jlk2 is expressed by primitive progenitors in fetal liver,6 it is conceivable that the FL-$t3/Jlk2 system may also be involved in the early stage of hematopoiesis at least during ontogeny.
